{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:27:19Z","timestamp":1781656039754,"version":"3.54.5"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003411","name":"Gangneung Asan Hospital","doi-asserted-by":"publisher","award":["2020IB006"],"award-info":[{"award-number":["2020IB006"]}],"id":[{"id":"10.13039\/501100003411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objective<\/jats:title>\n<jats:p>Rheumatoid arthritis (RA) increases the risk of cardiovascular disease. This study aimed to investigate the short-and long-term prognosis of patients with and without RA who underwent percutaneous coronary intervention (PCI).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The Korean National Health Insurance Service claims database was used to extract data on 236,134 patients (34,493 with RA and 201,641 without RA) who underwent PCI between 2008 and 2019. The primary outcome was major adverse cardiovascular events (MACE), including all-cause mortality, myocardial infarction, stroke, transient ischemic attack, or coronary revascularization with short-term (30-day) and long-term outcomes. The secondary outcomes were the individual components of MACE.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>During a 10-year follow-up, patients with RA showed a shorter median survival time from MACE than their counterparts (with RA: 4.29 years vs. without RA: 6.10 years). RA was significantly associated with an increased risk of MACEs in long-term outcomes (hazard ratio (HR) 1.07, 95% confidence intervals (CI) 1.06\u20131.09, <jats:italic>p<\/jats:italic>&lt;0.001), but not with short-term outcomes (HR 1.02, 95% CI 0.99\u20131.06, <jats:italic>p<\/jats:italic> = 0.222). RA was an independent predictor of an increased risk of all the MACE components.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In patients who underwent PCI, RA did not increase the risk of short-term cardiovascular outcomes but increased the risk of long-term adverse outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0281067","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T18:27:28Z","timestamp":1676399248000},"page":"e0281067","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: A Korean nationwide cohort study"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4275-6538","authenticated-orcid":true,"given":"Sang Jin","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-086X","authenticated-orcid":true,"given":"Hyesung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9442-3300","authenticated-orcid":true,"given":"Bo Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"pone.0281067.ref001","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"JA Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"pone.0281067.ref002","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"JA Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"pone.0281067.ref003","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk foctor for cardiovascular disease? A prospective study","volume":"61","author":"MJ Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"pone.0281067.ref004","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ard.2005.037978","article-title":"Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome","volume":"65","author":"KMJ Douglas","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"pone.0281067.ref005","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/ar3151","article-title":"Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population","volume":"12","author":"SV Doornum","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"pone.0281067.ref006","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/rheumatology\/kez639","article-title":"Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis","volume":"59","author":"S Martinez","year":"2020","journal-title":"Rheumatology"},{"key":"pone.0281067.ref007","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/annrheumdis-2015-207719","article-title":"Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study","volume":"75","author":"CH Lai","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"pone.0281067.ref008","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3899\/jrheum.120941","article-title":"Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis","volume":"40","author":"SS Mccoy","year":"2013","journal-title":"J Rheumatol"},{"key":"pone.0281067.ref009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jtcvs.2009.09.036","article-title":"Mortality after coronary artery revascularization of patients with rheumatoid arthritis","volume":"140","author":"JJ Varghese","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"pone.0281067.ref010","unstructured":"National Institute on Alcohol Abuse and Alcoholism [Internet]. Alcohol Facts and Statistics; Glossary [citated 2021 June 01]. Available from: https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/alcohol-facts-and-statistics."},{"key":"pone.0281067.ref011","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/art.21288","article-title":"Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors","volume":"52","author":"CP Chung","year":"2005","journal-title":"Arthritis Rheum"},{"key":"pone.0281067.ref012","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/annrheumdis-2013-204715","article-title":"The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"73","author":"J Zhang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"pone.0281067.ref013","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/rheumatology\/kes353","article-title":"Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study","volume":"52","author":"JA Avina-Zubieta","year":"2013","journal-title":"Rheumatology"},{"key":"pone.0281067.ref014","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/rheumatology\/kep225","article-title":"Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation","volume":"49","author":"IT Padol","year":"2010","journal-title":"Rheumatology"},{"key":"pone.0281067.ref015","doi-asserted-by":"crossref","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"BR England","year":"2018","journal-title":"BMJ"},{"key":"pone.0281067.ref016","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11926-018-0752-2","article-title":"Cardiovascular safety of biologics and JAK inhibitors in patients with rheumatoid arthritis","volume":"20","author":"EH Kang","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"pone.0281067.ref017","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/art.21932","article-title":"Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis","volume":"54","author":"SV Doornum","year":"2006","journal-title":"Arthritis Rheum"},{"key":"pone.0281067.ref018","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehv461","article-title":"Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome","volume":"36","author":"A Mantel","year":"2015","journal-title":"European Heart Journal"},{"key":"pone.0281067.ref019","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/heartjnl-2015-308634","article-title":"Repeat revascularization outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis","volume":"102","author":"MA Sintek","year":"2016","journal-title":"Heart"},{"key":"pone.0281067.ref020","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.amjcard.2011.11.056","article-title":"Outcomes of nonstenting percutaneous coronary intervention in patients with rheumatoid arthritis","volume":"109","author":"JH Kang","year":"2012","journal-title":"Am J Cardiol"},{"key":"pone.0281067.ref021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjcard.2020.10.048","article-title":"Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis.","volume":"140","author":"LP Dawson","year":"2021","journal-title":"Am J Cardiol"},{"key":"pone.0281067.ref022","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrrheum.2010.105","article-title":"Rheumatoid cachexia and cardiovascular disease","volume":"6","author":"GD Summers","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"pone.0281067.ref023","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"PW Wilson","year":"1998","journal-title":"Circulation"},{"key":"pone.0281067.ref024","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: A report of the American College of Cardiology\/American Heart Asssociation Task Force on clinical practice guidelines","volume":"139","author":"SM Grundy","year":"2019","journal-title":"Circulation"},{"key":"pone.0281067.ref025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.carrev.2020.07.018","article-title":"Drug-eluting stents versus bare-metal stents in large coronary artery revascularization: Systemic review and meta-analysis","volume":"23","author":"KH Changal","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"pone.0281067.ref026","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0140-6736(19)30474-X","article-title":"Drug-eluting or bare-metal stents for percutaneous coronary intervention; a systemic review and individual patient data meta-analysis of randomized clinical trials","volume":"393","author":"R Piccolo","year":"2019","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T18:27:52Z","timestamp":1676399272000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281067"}},"subtitle":[],"editor":[{"given":"Marcelo Arruda","family":"Nakazone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0281067","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]}}}